GLAUKOS CORP (GKOS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for GKOS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GKOS | Former Senior Vice President and Chief Financial Officer; Independent Director; Chair | 71 | ["Senior Vice President and Chief Financial Officer, Life Technologies Corporation","Chief Financial Officer, Invitrogen Corporation","Senior Partner, McKinsey & Company","Leader, McKinsey & Company, North American Chemical Practice","strong finance background","experience as a chief financial officer of a global biotechnology company","public company board experience","experience in the healthcare and chemical industries","private equity experience","strategy and organization experience"] | ["Compensation,NominatingandGovernance","Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| STEP | Director | 71 | [] | [] | 2026 |
| CE | Independent Director | 70 | ["Extensive knowledge of chemical and materials manufacturing","Significant knowledge of the medical and pharmaceutical industries","Strong insight into successful acquisition execution, integration, and synergy capture","Understanding of government and regulatory requirements","Strong expertise in corporate strategy","Governance / Risk Management experience","Financial Expert"] | ["Audit","Finance and Business Review","Nominating and Corporate Governance","Audit Committee","Nominating and Corporate Governance Committee","Stewardship Committee","Finance and Business Review Committee"] | 2025 |
| ICUI | [] | [] | 2020 |
Biography sourced from the proxy statement filing.
Age 71, Independent Director Since 2014 BOARD COMMITTEES Audit (Chair) TERM EXPIRES: 2028 BACKGROUND Senior Vice President and Chief Financial Officer, Life Technologies Corporation, a global biotechnology company (2008 to 2014) Chief Financial Officer, Invitrogen Corporation (2004 to 2008) Senior Partner, McKinsey & Company (1984 to 2004) Leader, McKinsey & Company, North American Chemical Practice (1998 to 2003) OTHER PUBLIC DIRECTORSHIPS Current Celanese Corporation (NYSE:CE) (2006 to current) ICU Medical, Inc. (Nasdaq:ICUI) (2018 to current) StepStone Group, Inc. (Nasdaq:STEP) (2020 to current) OTHER PRIVATE DIRECTORSHIPS Kaiser Permanente (2014 to current) EDUCATION Bachelor of Science, University of Minnesota M.B.A, University of Chicago KEY EXPERTISE PROVIDED TO THE BOARD: Mr. Hoffmeister s strong finance background, experience as a chief financial officer of a global biotechnology company, and public company board experience qualify him to serve on our Board of Directors. In addition, his experience in the healthcare and chemical industries, as well as his private equity, strategy and organization experience, contribute greatly to the knowledge base of our Board. KEY SKILLS Accounting and Auditing Capital Management Regulatory and Risk Management Medical Technology Mergers and Acquisitions Other Public Company Board Service